CN Patent

CN108367043A — 季铵化的微管溶素化合物的缀合物

Assigned to Seagen Inc · Expires 2018-08-03 · 8y expired

What this patent protects

公开了化合物和组合物，其中将季铵化的药物单元连接至靶向配体单元，含叔胺药物在被靶向的作用部位处从所述靶向配体单元释放。也公开了使用本发明的化合物和组合物治疗以被靶向的异常细胞为特征的疾病(诸如癌症或自身免疫病)的方法。

USPTO Abstract

公开了化合物和组合物，其中将季铵化的药物单元连接至靶向配体单元，含叔胺药物在被靶向的作用部位处从所述靶向配体单元释放。也公开了使用本发明的化合物和组合物治疗以被靶向的异常细胞为特征的疾病(诸如癌症或自身免疫病)的方法。

Drugs covered by this patent

Patent Metadata

Patent number
CN108367043A
Jurisdiction
CN
Classification
—
Expires
2018-08-03
Drug substance claim
No
Drug product claim
No
Assignee
Seagen Inc
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.